Bio-FD&C Co

Bio-FD&C Co FCF Margin

The Free Cash Flow Margin of Bio-FD&C Co (251120.KQ) as of Nov 18, 2026 is 32.48 %. In the previous year, Free Cash Flow Margin was 29.51 % — a change of 10.09% (higher).

FCF Margin

32.48 %

YoY

10.09%

Last updated:

Free Cash Flow Margin of Bio-FD&C Co is 2025 32.48 % . Free Cash Flow Margin of Bio-FD&C Co was 2024 29.51 % . It decreases by 10.09% higher compared to the previous year.

The Bio-FD&C Co FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
-0.99 KRW
Jan 1, 2019
34.73 KRW
Jan 1, 2020
2.65 KRW
Jan 1, 2021
-27.82 KRW
Jan 1, 2022
34.19 KRW
Jan 1, 2023
23.84 KRW
Jan 1, 2024
29.51 KRW
Jan 1, 2025
32.48 KRW
The Bio-FD&C Co FCF Margin history
YEARFCF MarginYoY
32.48 %+10.09%
29.51 %+23.76%
23.84 %-30.26%
34.19 %-222.91%
-27.82 %-1,150.40%
2.65 %-92.38%
34.73 %-3,622.00%
-0.99 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Free Cash Flow Margin of Bio-FD&C Co is 32.48 % in 2025.

Free Cash Flow Margin of Bio-FD&C Co changed from 29.51 % to 32.48 %, representing a 10.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Bio-FD&C Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bio-FD&C Co

All Key Metrics — Bio-FD&C Co